Pomerantz Law Firm Investigates Neogen Corporation Following FDA Warning Letter and Product Deaths
Pomerantz LLP has launched an investigation into Neogen Corporation (NASDAQ: NEOG) regarding potential securities fraud or unlawful business practices. The probe follows a U.S. Food and Drug Administration (FDA) warning letter issued on September 29, 2026, which linked the company's veterinary wound care product, HYCOAT, to serious infections and at least 20 horse deaths. The FDA noted that this incident represents the largest number of animal deaths ever associated with a quality defect in an FDA-regulated veterinary medical product. Although Neogen initiated a voluntary recall of HYCOAT in late January 2026, the regulatory findings have triggered legal scrutiny into whether company officers or directors misled investors regarding product safety and quality controls.
Tickers: $NEOG
Topics: Class Action Lawsuit FDA Warning Letter Product Recall Securities Fraud Investigation Veterinary Medicine Safety